Dr Richard Russell and Dr Omar Usmani discuss the results of studies in which LAMA/LABA treatment was given early in the course of COPD.
Dr Richard Russell and Dr Omar Usmani discuss the latest data relating to ICS use, including the successful withdrawal of ICS.
Dr Omar Usmani, an expert in inhaler devices, describes the importance of these for effective treatment of COPD.
Drs Russell and Usmani discuss various aspects comprising effective non-pharmacological management of COPD.
Dr Richard Russell and Dr Omar Usmani discuss the use and effect of e-cigarettes in patients with COPD.
Dr Richard Russell and Dr Omar Usmani discuss data from the 2015 ATS and ERS conferences on the comorbidities in patients with COPD.
Drs Russell and Usmani discuss data from the 2015 ATS and ERS conferences, about safety data and CV risk associated with pharmacological management of COPD
Following the 2015 ATS and ERS conferences, Drs Richard Russell and Omar Usmani discuss the challenges that primary care doctors face in recognising COPD.
Drs Richard Russell and Omar Usmani discuss the value of screening for patients at risk of COPD, and the impact of biomass fuels on COPD prevalence.
Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.